Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cruciani

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|November 21, 1998
Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysisS F Nielsen, S B Christensen, G Cruciani, et al.
Bioorganic & Medicinal Chemistry|July 1, 1997
Synthesis and antibacterial evaluation of [1,3]benzothiazino[3,2-a]quinoline- and [3,1]benzothiazino[1,2-a]quinoline-6-carboxylic acid derivativesV Cecchetti, G Cruciani, E Filipponi, et al.
Journal of Medicinal Chemistry|August 24, 2000
GRID/CPCA: a new computational tool to design selective ligandsM A Kastenholz, M Pastor, G Cruciani, et al.
Current Medical Research and Opinion|October 31, 2013
Clinical management patterns and treatment outcomes in patients with non-small cell lung cancer (NSCLC) across Europe: EPICLIN-Lung studyA Carrato, A Vergnenègre, M Thomas, et al.
Progress in Clinical and Biological Research|January 1, 1989
Response surfaces for modelling biological activities by principal properties of substituents: the CARSO procedureN Barbagianni, D Bonelli, D Cesareo, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 1998
Enhancement of radiation response by paclitaxel in mice according to different treatment schedulesA Cividalli, G Arcangeli, G Cruciani, et al.
Journal of Cancer Research and Clinical Oncology|June 30, 1998
Greater antitumor efficacy of paclitaxel administered before epirubicin in a mouse mammary carcinomaA Cividalli, G Cruciani, E Livdi, et al.
Mini Reviews in Medicinal Chemistry|November 26, 2009
Ligands of diltiazem binding site: an overview of some chemotypesR Budriesi, P Ioan, E Carosati, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|February 1, 1986
Modulated chemo-hormonotherapy in advanced breast cancer. A pilot studyA Tienghi, G Rosti, G M Fiorentini, et al.
Journal of Medicinal Chemistry|March 26, 1999
6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysisR Mannhold, G Cruciani, H Weber, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|November 21, 1998
Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysisS F Nielsen, S B Christensen, G Cruciani, et al.
Bioorganic & Medicinal Chemistry|July 1, 1997
Synthesis and antibacterial evaluation of [1,3]benzothiazino[3,2-a]quinoline- and [3,1]benzothiazino[1,2-a]quinoline-6-carboxylic acid derivativesV Cecchetti, G Cruciani, E Filipponi, et al.
Journal of Medicinal Chemistry|August 24, 2000
GRID/CPCA: a new computational tool to design selective ligandsM A Kastenholz, M Pastor, G Cruciani, et al.
Current Medical Research and Opinion|October 31, 2013
Clinical management patterns and treatment outcomes in patients with non-small cell lung cancer (NSCLC) across Europe: EPICLIN-Lung studyA Carrato, A Vergnenègre, M Thomas, et al.
Progress in Clinical and Biological Research|January 1, 1989
Response surfaces for modelling biological activities by principal properties of substituents: the CARSO procedureN Barbagianni, D Bonelli, D Cesareo, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 1998
Enhancement of radiation response by paclitaxel in mice according to different treatment schedulesA Cividalli, G Arcangeli, G Cruciani, et al.
Journal of Cancer Research and Clinical Oncology|June 30, 1998
Greater antitumor efficacy of paclitaxel administered before epirubicin in a mouse mammary carcinomaA Cividalli, G Cruciani, E Livdi, et al.
Mini Reviews in Medicinal Chemistry|November 26, 2009
Ligands of diltiazem binding site: an overview of some chemotypesR Budriesi, P Ioan, E Carosati, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|February 1, 1986
Modulated chemo-hormonotherapy in advanced breast cancer. A pilot studyA Tienghi, G Rosti, G M Fiorentini, et al.
Journal of Medicinal Chemistry|March 26, 1999
6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysisR Mannhold, G Cruciani, H Weber, et al.
Pageof 8